Global Retirement Partners’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-200
Closed -$5.89K 3767
2024
Q3
$5.89K Sell
200
-2,000
-91% -$46.1K ﹤0.01% 2497
2024
Q2
$27.2K Buy
+2,200
New +$46.4K ﹤0.01% 1833
2023
Q1
Sell
-500
Closed -$14.8K 3322
2022
Q4
$14.8K Hold
500
﹤0.01% 1614
2022
Q3
$18K Hold
500
﹤0.01% 1451
2022
Q2
$14K Hold
500
﹤0.01% 1499
2022
Q1
$13K Buy
+500
New +$21.2K ﹤0.01% 1528
2021
Q4
Sell
-500
Closed -$31K 1488
2021
Q3
$31K Hold
500
﹤0.01% 1037
2021
Q2
$43K Buy
+500
New +$26.8K ﹤0.01% 921

Other funds holding FLNA

Global Retirement Partners's FLNA Position: Q4 2024 in Review

Global Retirement Partners sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 200 shares — an estimated $5.89K sold.

Global Retirement Partners first reported a position in FLNA in Q2 2021 and held it in 8 quarters. The position peaked at $43K in Q2 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Global Retirement Partners reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Global Retirement Partners sold 200 Filana Therapeutics shares in Q4 2024, an estimated $5.89K.
  • Global Retirement Partners first reported a position in Filana Therapeutics in Q2 2021 and held it in 8 quarters.
  • Global Retirement Partners's Filana Therapeutics position peaked at $43K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.